Clinical Trial Update: An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies [Phase 3]

View source ↗

Summary

Open-label extension study assessing long-term safety and tolerability of RO7234292 (RG6042) in Huntington's disease participants from prior Roche/Genentech tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• RG6042 (RG6042)
• RO7234292 (RO7234292)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-08-31